Search results
Feb 12, 2024 · Shock therapy, known medically as electroconvulsive therapy (ECT), is a treatment for major depressive disorder (MDD), bipolar disorder, and other psychiatric conditions. ECT is generally offered when other treatments are ineffective or there is a need for rapid response. ECT has a stigma attached to it from the early days of shock therapy, but ...
Jan 5, 2024 · ECT is an effective, generally safe, and last resort treatment option for severe depression. A doctor may only recommend it if your depression does not respond to first-line treatments, like ...
Jan 11, 2022 · Shock treatment for depression often produces a dramatic improvement in symptoms, especially in elderly individuals, sometimes during the first week of treatment. While it is estimated many of these patients will experience a future return of depression symptoms , the prognosis for each episode of depression is good.
Feb 16, 2022 · Electroconvulsive Therapy. Electroconvulsive therapy (ECT) has been an essential treatment for severe mood and psychotic disorders for many decades, and its use is supported by evidence of ...
People also ask
Can shock therapy help with depression?
What is the prognosis of shock treatment for depression?
What is shock therapy?
Jul 22, 2021 · Key Takeaways. Researchers found that electroconvulsive therapy (ECT) is a safe treatment, especially when compared to the risks associated with severe depression. Patients who received ECT were less at risk of suicide, compared to those who didn't. People with severe depression who might benefit from ECT are often reluctant to receive the ...
- Sarah Simon
Jul 24, 2023 · ECT is a highly efficacious treatment for major depression and several other psychiatric disorders. Several meta-analyses support ECT’s superior antidepressant efficacy compared to sham-ECT in ...
May 9, 2018 · The U-M team’s model suggests that instead of spending half of the four years after diagnosis with active depression symptoms, patients could be symptom-free two-thirds of the time. The study predicts ECT as a third-line treatment would have an incremental cost-effectiveness ratio of $54,000 per quality-adjusted life year.